Nektar Therapeutics(NKTR)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
NKTR is scheduled to report on Nov 5, 2026, after the market closes. Analysts expect EPS of -$2.11.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±4.7%).
Did the stock rise after good news?
The next-day move after each of its last 8 EPS beats and 3 misses.
In plain words: it beat expectations 8 times, but the stock still fell 3 of those 8 times.
- Aug '26Beat▼ -3.8%
- May '26Missed▼ -1.8%
- Mar '26Beat▲ +4.1%
- Nov '25Beat▲ +1.5%
- Aug '25Beat▲ +6.0%
- May '25Missed▼ -4.8%
- Mar '25Beat▼ 0.0%
- Nov '24Beat▲ +2.2%
- Aug '24Beat▼ -8.3%
- May '24Beat▲ +10.0%
- Nov '23Missed▼ -9.1%
Clear beats and misses with a known reaction only. What counts as a beat
Why did NKTR fall after beating earnings?
2 of NKTR's last 11 reactions went against the EPS result. What stands out in each:
NKTR beat EPS estimates in 8 quarters, and the stock still closed lower the next day 2 times.
- Aug 13, 2026EPS beat +40.7%stock -3.8% next day
- It had risen 13.2% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.5% lower as soon as trading resumed.
- Aug 8, 2024EPS beat +6.6%stock -8.3% next day
- It opened 4.1% lower as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was NKTR's earnings move already priced in?
NKTR's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does NKTR hold its opening gap after earnings?
NKTR's opening move after each report and where it closed that day.
In 10 reports NKTR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%), and fully reversed 1 time. Gaps up faded 2 of 6; gaps down recovered 0 of 4.
- Aug 13, 2026HeldOpened -2.5%, closed -3.8%
- May 7, 2026ReversedOpened +1.9%, closed -1.8%
- Mar 12, 2026HeldOpened +3.2%, closed +4.1%
- Nov 6, 2025HeldOpened +1.6%, closed +1.5%
- Aug 7, 2025HeldOpened +3.9%, closed +6.0%
- May 8, 2025HeldOpened -3.2%, closed -4.8%
- Mar 12, 2025FadedOpened +7.3%, closed 0.0%
- Aug 8, 2024HeldOpened -4.1%, closed -8.3%
NKTR earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | After close | -$2.04 | -$1.21 | +40.7% | -3.82% | -3.00% |
| May 7, 2026 | After close | -$1.48 | -$1.78 | -20.3% | -1.78% | -5.93% |
| Mar 12, 2026 | After close | -$3.49 | -$1.29 | +63.0% | +4.11% | +6.68% |
| Nov 6, 2025 | After close | -$2.79 | -$1.87 | +33.0% | +1.54% | +7.51% |
| Aug 7, 2025 | After close | -$3.12 | -$2.78 | +10.9% | +6.02% | +8.51% |
| May 8, 2025 | After close | -$2.82 | -$3.61 | -28.0% | -4.84% | +14.52% |
| Mar 12, 2025 | After close | -$2.92 | -$2.25 | +22.9% | 0.00% | +10.98% |
| Nov 7, 2024 | After close | -$3.09 | -$2.65 | +14.2% | +2.19% | -4.38% |
| Aug 8, 2024 | After close | -$3.01 | -$2.81 | +6.6% | -8.26% | -4.96% |
| May 9, 2024 | After close | -$3.07 | -$2.76 | +10.1% | +10.00% | +10.63% |
| Mar 4, 2024 | After close | -$2.94 | -$3.30 | -12.2% | — | — |
| Nov 7, 2023 | After close | -$2.40 | -$2.85 | -18.8% | -9.09% | -18.18% |
Consensus for the next report: EPS -$2.11, revenue $10.48M.
NKTR Earnings FAQ
Answers computed from Nektar Therapeutics's reported history
NKTR is scheduled to report on Nov 5, 2026, after the market closes. Analysts expect EPS of -$2.11.
Over the last 12 quarters with a usable EPS surprise, NKTR beat the consensus estimate 8 times (67%), missed 4 and landed in line 0.
Across its last 11 quarters with a measured reaction, NKTR moved an average of ±4.7% in the first session after reporting. It closed higher 46% of the time; the largest gain was 10.0% and the largest drop -9.1%.
NKTR fell in the first session after 2 of its last 8 EPS beats (25%). A beat that was already priced in, or weaker guidance, can send a stock lower.
Across its last 11 quarters with price data, NKTR moved an average of +5.1% in the 20 trading sessions before reporting and was higher in 73% of them. After a run-up of 3% or more (6 quarters), it fell the next day 50% of the time, averaging -0.7%. This describes past reports; it is not a forecast.
In 10 reports NKTR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%), and fully reversed once. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · NKTR: 12 reported quarters, latest Aug 13, 2026. Information only, not investment advice.
Looking for more on NKTR?
Price charts, forecast, fundamentals and risk pages for NKTR are not on Tickzen yet. You can run a full stock analysis now.
Run the NKTR Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun